NCT03665311View on ClinicalTrials.gov

Saline Versus Albumin Fluid for Extracorporeal Removal With Slow Low Efficiency Dialysis Feasibility Study

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

January 15, 2020

Study Completion Date

January 15, 2020

Conditions
Renal Replacement TherapyAcute Kidney InjuryHypotension
Interventions
BIOLOGICAL

25% Albumin fluid

25% Albumin fluid (100 mL)

OTHER

Normal Saline

0.9% Normal Saline (100 mL)

Trial Locations (1)

K2G 2H1

The Ottawa Hospital, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER